| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 94325AJ25N |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Toll-like receptor 3 agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Encephalomyelitis | 3 | D004679 | ClinicalTrials |
| Fatigue Syndrome, Chronic | 3 | D015673 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Post-Acute COVID-19 Syndrome | 2 | D000094024 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 1 | D045169 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Breast Carcinoma In Situ | 1 | D000071960 | ClinicalTrials |
| Breast Neoplasms, Male | 1 | D018567 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107862 |
| FDA SRS | 94325AJ25N |
CONTENTS